Literature DB >> 4569059

Regression of intradermal malignant melanoma after intralesional injection of Mycobacterium bovis strain BCG.

L Nathanson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4569059

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  13 in total

1.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

2.  Production of 5-15 microns diameter alginate-polylysine microcapsules by an air-atomization technique.

Authors:  K K Kwok; M J Groves; D J Burgess
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

Review 3.  The role of immunotherapy in the management of patients with malignant melanoma.

Authors:  J E Goodnight; D L Morton
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

Review 4.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

5.  Immunotherapy as an adjunct to surgery in the treatment of cancer.

Authors:  F R Eilber; E C Holmes; D L Morton
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

6.  BCG hydrogel promotes CTSS-mediated antigen processing and presentation, thereby suppressing metastasis and prolonging survival in melanoma.

Authors:  Mirela Kremenovic; Alfred A Chan; Bing Feng; Lukas Bäriswyl; Steve Robatel; Thomas Gruber; Li Tang; Delphine J Lee; Mirjam Schenk
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

7.  Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression.

Authors:  A Bekierkunst; L Wang; R Toubiana; E Lederer
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

8.  Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).

Authors:  G J Hill; R Ruess; R Berris; G W Philpott; P Parkin
Journal:  Ann Surg       Date:  1974-08       Impact factor: 12.969

9.  Hypotension and disseminated intravascular coagulation following intralesional bacillus Calmette-Guérin therapy for locally metastatic melanoma.

Authors:  M H Cohen; R J Elin; B J Cohen
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 10.  BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases.

Authors:  Alok K Singh; Mihai G Netea; William R Bishai
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.